Conestoga Capital Advisors Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Dorman Products
DORM
|
+$21.5M |
| 2 |
RAVN
Raven Industries Inc
RAVN
|
+$16.8M |
| 3 |
HealthStream
HSTM
|
+$16.5M |
| 4 |
CMD
Cantel Medical Corporation
CMD
|
+$14.6M |
| 5 |
SPS Commerce
SPSC
|
+$13.3M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ACCL
Accelrys Inc
ACCL
|
+$20.3M |
| 2 |
CoStar Group
CSGP
|
+$16.9M |
| 3 |
Factset
FDS
|
+$14.3M |
| 4 |
AeroVironment
AVAV
|
+$13.6M |
| 5 |
VIVO
Meridian Bioscience Inc
VIVO
|
+$5.98M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 24.23% |
| 2 | Healthcare | 16.21% |
| 3 | Industrials | 15.07% |
| 4 | Materials | 8.3% |
| 5 | Consumer Discretionary | 7.14% |
Similar funds
Conestoga Capital Advisors's Q1 2014 Portfolio in Review
As of Q1 2014, Conestoga Capital Advisors held 140 positions worth $1.58B, up 6.2% from $1.49B the previous quarter. Its ten largest holdings account for 29% of the portfolio.
Conestoga Capital Advisors deployed $199M of net new capital in Q1 2014, opening 2 new positions and adding to 50 existing holdings. Its largest new stake was Cantel Medical Corporation: 444,000 shares worth $15M.
By sector, the portfolio is most concentrated in Technology at 24% of assets, down from 25% a quarter earlier, followed by Healthcare and Industrials.
On the sell side, the largest reduction was CoStar Group, an estimated $16.9M trimmed.
- Conestoga Capital Advisors's largest Q1 2014 buy was Cantel Medical Corporation: 444,000 shares worth $15M.
- Conestoga Capital Advisors added most to Dorman Products in Q1 2014, an estimated $21.5M increase.
- Conestoga Capital Advisors's biggest Q1 2014 reduction was CoStar Group, cutting an estimated $16.9M.
- Conestoga Capital Advisors fully exited Accelrys Inc in Q1 2014, selling an estimated $20.3M.
- Conestoga Capital Advisors's ten largest holdings make up 29% of its $1.58B portfolio in Q1 2014.
- Conestoga Capital Advisors opened 2 new positions and closed 5 in Q1 2014.
- Conestoga Capital Advisors's portfolio value rose 6.2% quarter-over-quarter to $1.58B.
Based on Conestoga Capital Advisors's 13F filing for Q1 2014, filed 23 Apr 2014.